{"entity":{"type":"insider","cik":"0001313942","url":"/insider/0001313942","json_url":"/insider/0001313942.json","name":"Mow Jonathan P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2018-12-11","last":"2018-12-17","span_basis":"filed_date"},"name_variants":[{"name":"Mow Jonathan P","source":"filing","n_filings":3,"first_seen":"2018-12-11","last_seen":"2018-12-17"}],"transactions":[{"id":6498968,"accession":"0001209191-18-062931","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-062931","line_url":"/filing/0001209191-18-062931#line-1","is_derivative":false,"issuer_cik":"0001169245","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001169245","owner_cik":"0001313942","owner_name":"Mow Jonathan P","owner_display_name":"Mow Jonathan P","owner_url":"/insider/0001313942","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.69,"price_display":"3.69","price_state":"stated","total_value":3690.0,"total_display":"3,690.00","total_whole":"3,690","shares_owned_after":51199.0,"shares_owned_after_display":"51,199","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-13","filed_date":"2018-12-17","scope":"insider"},{"id":9270744,"accession":"0001209191-18-062480","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-062480","line_url":"/filing/0001209191-18-062480#line-2","is_derivative":false,"issuer_cik":"0001313942","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001313942","owner_cik":"0001313942","owner_name":"Mow Jonathan P","owner_display_name":"Mow Jonathan P","owner_url":"/insider/0001313942","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":3080.0,"total_display":"3,080.00","total_whole":"3,080","shares_owned_after":50199.0,"shares_owned_after_display":"50,199","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-13","scope":"insider"},{"id":6524644,"accession":"0001209191-18-061982","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-061982","line_url":"/filing/0001209191-18-061982#line-2","is_derivative":false,"issuer_cik":"0001169245","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001169245","owner_cik":"0001313942","owner_name":"Mow Jonathan P","owner_display_name":"Mow Jonathan P","owner_url":"/insider/0001313942","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":3080.0,"total_display":"3,080.00","total_whole":"3,080","shares_owned_after":51699.0,"shares_owned_after_display":"51,699","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-11","scope":"insider"},{"id":9270743,"accession":"0001209191-18-062480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-062480","line_url":"/filing/0001209191-18-062480#line-1","is_derivative":false,"issuer_cik":"0001313942","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001313942","owner_cik":"0001313942","owner_name":"Mow Jonathan P","owner_display_name":"Mow Jonathan P","owner_url":"/insider/0001313942","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":3.89,"price_display":"3.89","price_state":"stated","total_value":2723.0,"total_display":"2,723.00","total_whole":"2,723","shares_owned_after":49399.0,"shares_owned_after_display":"49,399","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-13","scope":"insider"},{"id":6524641,"accession":"0001209191-18-061982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061982","line_url":"/filing/0001209191-18-061982#line-1","is_derivative":false,"issuer_cik":"0001169245","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001169245","owner_cik":"0001313942","owner_name":"Mow Jonathan P","owner_display_name":"Mow Jonathan P","owner_url":"/insider/0001313942","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":3.88,"price_display":"3.88","price_state":"stated","total_value":8536.0,"total_display":"8,536.00","total_whole":"8,536","shares_owned_after":50899.0,"shares_owned_after_display":"50,899","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001169245","name":"PhaseBio Pharmaceuticals Inc","url":"/issuer/0001169245","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2018-12-11","last_seen":"2018-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001313942","retrieved_at":"2026-08-27T13:32:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}